Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human β-hexosaminidase A on the accumulated GM2 ganglioside
Open Access
- 23 September 2005
- journal article
- research article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 50 (9) , 460-467
- https://doi.org/10.1007/s10038-005-0278-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From MilkPediatrics, 2004
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)The Journal of Pediatrics, 2004
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Establishment and characterization of immortalized Schwann cells from murine model of Niemann-Pick disease type C (spm/spm)Journal of the Peripheral Nervous System, 2001
- Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff DiseasesHuman Molecular Genetics, 1996
- Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolismNature Genetics, 1995
- Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth‐promoting activitiesJournal of Neuroscience Research, 1995
- Mitogenic effects of platelet‐derived growth factor, fibroblast growth factor, transforming growth factor‐β, and heparin‐binding serum factor for adult mouse Schwann cellsJournal of Neuroscience Research, 1994
- Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosidesBiochimica et Biophysica Acta (BBA) - General Subjects, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991